Overview

COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria

Status:
Terminated
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
This study was designed to determine whether COREG MR is more effective than TOPROL-XL in reducing microalbuminuria in type 2 diabetic or non-diabetic patients with high blood pressure and microalbuminuria.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Carvedilol
Lisinopril
Metoprolol